INDIGO Now Offers Profiling of Genes Regulated by Nuclear Receptors

Share Article

Critical step in understanding the downstream genomic impact of interactions with Nuclear Receptors.

News Image
We are excited to add Gene Expression services to our portfolio. It represents a significant expansion opportunity and enhances our industry leading position.

INDIGO Biosciences Inc., a recognized industry-leading provider of nuclear receptor products and services, announced today that it has expanded its service portfolio by offering analyses of nuclear receptor regulated genes.

Gene expression is a widely used approach for characterizing biological perturbations, defining the molecular mechanisms of diseases and making critical decisions about risks associated with compounds of interest. INDIGO’s highly-trained specialists can provide a comprehensive offering of genomic services including RNA extraction, qPCR services, microarray services, and microarray data analysis. They will help you identify the appropriate technology, experimental design and program goals to ensure that your needs will be met.

  •     INDIGO offers predesigned panels of optimized primers for NR targets.
  •     Experience in gene selection for disease and pathway-specific studies including inflammation, cancer, diabetes, and drug metabolism-related gene expression.
  •     INDIGO provides data on mRNA levels relative to a housekeeping gene, statistical analysis and interpretation in their study report.

Changes in the gene expression of nuclear receptor targets control the progression of metabolic disease, hypertension, inflammation, bone density, reproductive disorders, and gender differentiation. “We are excited to add Gene Expression Services to our portfolio. It represents a significant expansion opportunity and enhances our industry leading position,” says Dr. Jack Vanden Heuvel, Chief Scientific Officer.

About INDIGO Biosciences, Inc.
INDIGO Biosciences was founded in 2005 in State College, Pennsylvania, and has established itself as an industry-leading provider of both products and services focused on nuclear receptors. INDIGO offers both screening services and assay kits for the pharmaceutical, biotechnology, agri-business, nutriceutical industries, as well as government research agencies and academic researchers.

For more information on INDIGO’s products or services, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tonya Daher
INDIGO Biosciences, Inc.
+1 (814) 234-1919 Ext: 133
Email >
Follow >
Visit website